Literature DB >> 24656849

Estimating long-term multivariate progression from short-term data.

Michael C Donohue1, Hélène Jacqmin-Gadda2, Mélanie Le Goff2, Ronald G Thomas3, Rema Raman4, Anthony C Gamst4, Laurel A Beckett5, Clifford R Jack6, Michael W Weiner7, Jean-François Dartigues8, Paul S Aisen3.   

Abstract

MOTIVATION: Diseases that progress slowly are often studied by observing cohorts at different stages of disease for short periods of time. The Alzheimer's Disease Neuroimaging Initiative (ADNI) follows elders with various degrees of cognitive impairment, from normal to impaired. The study includes a rich panel of novel cognitive tests, biomarkers, and brain images collected every 6 months for as long as 6 years. The relative timing of the observations with respect to disease pathology is unknown. We propose a general semiparametric model and iterative estimation procedure to estimate simultaneously the pathological timing and long-term growth curves. The resulting estimates of long-term progression are fine-tuned using cognitive trajectories derived from the long-term "Personnes Agées Quid" study.
RESULTS: We demonstrate with simulations that the method can recover long-term disease trends from short-term observations. The method also estimates temporal ordering of individuals with respect to disease pathology, providing subject-specific prognostic estimates of the time until onset of symptoms. When the method is applied to ADNI data, the estimated growth curves are in general agreement with prevailing theories of the Alzheimer's disease cascade. Other data sets with common outcome measures can be combined using the proposed algorithm. AVAILABILITY: Software to fit the model and reproduce results with the statistical software R is available as the grace package. ADNI data can be downloaded from the Laboratory of NeuroImaging.
Copyright © 2014 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Growth curves; Multiple outcomes; Progression curves; Self-modeling regression; Semiparametric regression

Mesh:

Year:  2014        PMID: 24656849      PMCID: PMC4169767          DOI: 10.1016/j.jalz.2013.10.003

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  15 in total

1.  Self-modeling for two-dimensional response curves.

Authors:  W M Ladd; M J Lindstrom
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

2.  Self modeling with flexible, random time transformations.

Authors:  Lyndia C Brumback; Mary J Lindstrom
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

3.  Nonlinear mixed effects models for repeated measures data.

Authors:  M L Lindstrom; D M Bates
Journal:  Biometrics       Date:  1990-09       Impact factor: 2.571

4.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

5.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

6.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

7.  Biomarkers for Alzheimer's: the sequel of an original model.

Authors:  Giovanni B Frisoni; Kaj Blennow
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

8.  Shape-invariant modeling of circadian rhythms with random effects and smoothing spline ANOVA decompositions.

Authors:  Yuedong Wang; Chunlei Ke; Morton B Brown
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

9.  Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.

Authors:  Hélène Amieva; Mélanie Le Goff; Xavier Millet; Jean Marc Orgogozo; Karine Pérès; Pascale Barberger-Gateau; Hélène Jacqmin-Gadda; Jean François Dartigues
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422

10.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Authors:  Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

View more
  60 in total

1.  Simulating the outcome of amyloid treatments in Alzheimer's disease from imaging and clinical data.

Authors:  Clément Abi Nader; Nicholas Ayache; Giovanni B Frisoni; Philippe Robert; Marco Lorenzi
Journal:  Brain Commun       Date:  2021-04-28

2.  Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.

Authors:  Philip S Insel; Niklas Mattsson; R Scott Mackin; Michael Schöll; Rachel L Nosheny; Duygu Tosun; Michael C Donohue; Paul S Aisen; William J Jagust; Michael W Weiner
Journal:  Neurology       Date:  2016-04-15       Impact factor: 9.910

3.  Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.

Authors:  Murat Bilgel; Rebecca L Koscik; Yang An; Jerry L Prince; Susan M Resnick; Sterling C Johnson; Bruno M Jedynak
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

5.  Disease progression models for dominantly-inherited Alzheimer's disease.

Authors:  Dan Li; Michael C Donohue
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

Review 6.  Cerebral Amyloid Angiopathy, Alzheimer's Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets.

Authors:  J Weldon Furr; Diego Morales-Scheihing; Bharti Manwani; Juneyoung Lee; Louise D McCullough
Journal:  Neuromolecular Med       Date:  2019-10-04       Impact factor: 3.843

7.  A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging.

Authors:  Murat Bilgel; Jerry L Prince; Dean F Wong; Susan M Resnick; Bruno M Jedynak
Journal:  Neuroimage       Date:  2016-04-16       Impact factor: 6.556

8.  A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease.

Authors:  Guoqiao Wang; Scott Berry; Chengjie Xiong; Jason Hassenstab; Melanie Quintana; Eric M McDade; Paul Delmar; Matteo Vestrucci; Gopalan Sethuraman; Randall J Bateman
Journal:  Stat Med       Date:  2018-05-14       Impact factor: 2.373

9.  Cognitive/Clinical Endpoints for Pre-Dementia AD Trials.

Authors:  P S Aisen
Journal:  J Prev Alzheimers Dis       Date:  2015

Review 10.  The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Jennifer Salazar; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2016-12-05       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.